On June 18th, 2025, Tsinghua University Press (TUP) and Elsevier Inc. jointly launched the English edition of Medicinal Chemistry and Drug Development at the China National Convention Center. Edited by Professor LIU Gang from Tsinghua University, the book systematically presents innovative approaches in medicinal chemistry in the era of artificial intelligence through 30 representative drug discovery case studies. Dr. LU Xianhe, General Editor of TUP, Dr. Glyn Jones, Publisher at Elsevier, and Professor LIU Gang unveil the new book together, drawing widespread attention from experts and scholars.
Book Launch of Medicinal Chemistry and Drug Development
In his speech titled “Innovating for Life: China's Contribution in Global Case Studies”, Dr. LU Xianhe highlights the timely publication of Medicinal Chemistry and Drug Development at the dynamic intersection of intelligent technologies and pharmaceutical sciences. He emphasizes that the book provides both theoretical guidance and practical insights, laying the groundwork for advancing intelligent drug discovery. This cross-border collaboration, LU notes, brings together leading experts from academia, industry, and research institutions, offering both academic depth and practical value. He believes that the book will offer fresh perspectives for global researchers, particularly in fostering innovation at the intersection of AI and pharmaceutical sciences. LU concludes by reaffirming TUP's commitment to deepening international collaborations to deliver more cutting-edge academic content.
Speech by Dr. LU Xianhe, General Editor of TUP
Glyn Jones highlights in his remarks that Medicinal Chemistry and Drug Development presents the pivotal role of medicinal chemistry throughout the drug research process. From early-stage target discovery to late-stage drug candidate optimization, medicinal chemistry not only drives breakthroughs in molecular design but also significantly improves pharmacokinetic properties. He points out that such interdisciplinary collaboration is key to developing safe and effective medicines. He states that the book will serve as an essential guide for researchers worldwide, and expresses eagerness to strengthen cooperation to promote global sharing of pharmaceutical research achievements.
Dr. Glyn Jones, publisher of Elsevier, delivers a speech
Professor LIU Gang offers an in-depth overview of the book's content, distinctive features, and editorial principles. By bridging theory and practice, the book integrates multidisciplinary expertise, setting a model for collaborative knowledge creation. He explains that the editorial team focuses on showcasing the narrative power of medicinal chemistry within modern drug innovation. Through detailed examination of its critical role in lead optimization and clinical candidate selection, the book translates complex technical concepts into compelling intellectual discourse. This approach supports talent cultivation in cutting-edge therapeutic research. Professor LIU extends special thanks to the academic and industrial contributors as well as Elsevier and TUP for bringing China's pharmaceutical research results to the world.
Professor LIU Gang presents an overview of the book
The publication of Medicinal Chemistry and Drug Development offers a practical reference for researchers worldwide, enabling students, scientists, and pharmaceutical professionals from different countries to access core knowledge in drug design and development, thereby fostering international exchange in foundational technologies.
Chinese Edition of Medicinal Chemistry and Drug Development
English Edition of Medicinal Chemistry and Drug Development
